Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.14
+0.16 (3.21%)
Dec 20, 2024, 4:00 PM EST - Market closed
Foghorn Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 25.52 | 34.16 | 19.23 | 1.32 | 0.43 | - | Upgrade
|
| Revenue Growth (YoY) | -21.66% | 77.63% | 1357.77% | 206.74% | - | - | Upgrade
|
| Cost of Revenue | 107.81 | 109.69 | 105.62 | 80.33 | 57.72 | 44.36 | Upgrade
|
| Gross Profit | -82.3 | -75.53 | -86.39 | -79.01 | -57.29 | -44.36 | Upgrade
|
| Selling, General & Admin | 29.03 | 32.37 | 30.75 | 21.73 | 11.25 | 6.72 | Upgrade
|
| Research & Development | -9.59 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 19.44 | 32.37 | 30.75 | 21.73 | 11.25 | 6.72 | Upgrade
|
| Operating Income | -101.74 | -107.91 | -117.14 | -100.73 | -68.53 | -51.08 | Upgrade
|
| Interest Expense | - | - | - | -1.91 | -0.98 | -0.54 | Upgrade
|
| Interest & Investment Income | 11.46 | 10.88 | 5.68 | 0.06 | 0.1 | 0.5 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.44 | 2.83 | 2.58 | 2.49 | 0.83 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -86.84 | -94.2 | -108.88 | -100.09 | -68.58 | -51.13 | Upgrade
|
| Other Unusual Items | - | - | - | -1.23 | -0.22 | - | Upgrade
|
| Pretax Income | -89.24 | -94.2 | -108.88 | -101.32 | -68.8 | -51.13 | Upgrade
|
| Income Tax Expense | 1.99 | 4.23 | - | - | - | - | Upgrade
|
| Net Income | -91.22 | -98.43 | -108.88 | -101.32 | -68.8 | -51.13 | Upgrade
|
| Net Income to Common | -91.22 | -98.43 | -108.88 | -101.32 | -68.8 | -51.13 | Upgrade
|
| Shares Outstanding (Basic) | 50 | 42 | 42 | 37 | 11 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 42 | 42 | 37 | 11 | 4 | Upgrade
|
| Shares Change (YoY) | 18.80% | 0.92% | 11.89% | 236.49% | 163.53% | 42.25% | Upgrade
|
| EPS (Basic) | -1.83 | -2.34 | -2.62 | -2.73 | -6.23 | -12.20 | Upgrade
|
| EPS (Diluted) | -1.83 | -2.34 | -2.62 | -2.73 | -6.23 | -12.20 | Upgrade
|
| Free Cash Flow | -103.89 | -119.33 | 192.4 | -53.56 | -47.47 | -47.3 | Upgrade
|
| Free Cash Flow Per Share | -2.09 | -2.84 | 4.63 | -1.44 | -4.30 | -11.28 | Upgrade
|
| Gross Margin | - | -221.15% | - | - | - | - | Upgrade
|
| Operating Margin | -398.74% | -315.93% | -609.20% | -7637.15% | -15937.44% | - | Upgrade
|
| Profit Margin | -357.53% | -288.17% | -566.27% | -7681.58% | -16000.00% | - | Upgrade
|
| Free Cash Flow Margin | -407.18% | -349.38% | 1000.63% | -4060.88% | -11039.30% | - | Upgrade
|
| EBITDA | -98.53 | -104.46 | -113.82 | -97.51 | -67.2 | -50.39 | Upgrade
|
| D&A For EBITDA | 3.21 | 3.45 | 3.32 | 3.23 | 1.33 | 0.69 | Upgrade
|
| EBIT | -101.74 | -107.91 | -117.14 | -100.73 | -68.53 | -51.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.